Table 2.

Comparison of cardiac function indexes of patients in both groups two weeks and four months after the treatment (x̅±s)

Observation index	Treatment group			Matched group
	Before the treatment	Two weeks after the treatment	Fourth months after the treatment	Before the treatment	Two weeks after the treatment	Fourth months after the treatment
SBP (mmHg)	157.8±15.8	140.9±12.5*,#	126.4±10.3*,#	156.5±15.6	145.3±13.3*	133.8±11.4*
LVIDs (mm)	48.4±3.7	40.6±3.4*,#	32.1±3.1*,#	48.6±3.5	45.4±3.5*	38.2±3.3*
PWTs (mm)	11.7±1.5	11.1±1.4*,#	10.5±1.3*,#	11.8±1.6	11.5±1.4*	10.9±1.5*
EDV (ml)	180.2±20.5	172.1±19.3	163.8±18.6	179.5±20.1	172.3±19.6	164.3±18.4
ET (ms)	246.8±28.5	262.2±31.5*,#	280.3±36.4*,#	247.2±28.1	256.9±33.3*	266.3±38.5
SV (mL)	47.3±13.9	48.8±14.5*,#	55.1±15.9*,#	47.2±13.3	48.4±15.2*	52.7±15.6*
LVEF (%)	42.3±5.7	49.8±6.2*,#	61.9±6.9*,#,Δ	42.1±5.4	46.1±6.1*	50.8±6.5*
FS (%)	15.5±2.3	19.3±5.4*,#	32.3±5.7*,#,Δ	14.8±3.7	17.4±4.3*	26.2±4.3*
cESS (kdyn/cm2)	322.2±31.7	251.3±29.5*,#,Δ	186.5±22.1*,#	319.7±32.2	277.6±28.7*	234.1±26.3*
MEE (cal/systole)	1.59±0.48	1.35±0.36*,#,Δ	1.20±0.24*,#	1.57±0.45	1.46±0.41*	1.38±0.38*

Note: Compare with that before the treatment;

^* P<0.05.

Compare with the matched group;

^# P<0.05.

Compare with another time in the same group;

^Δ P<0.01.